Market Closed -
Nasdaq
01:29:51 31/05/2024 am IST
|
5-day change
|
1st Jan Change
|
6.71
USD
|
-0.15%
|
|
-11.24%
|
0.00%
|
Fiscal Period: December |
2024
|
2025
|
2026
|
---|
Capitalization
1 |
321.9
|
-
|
-
|
Enterprise Value (EV)
1 |
546.8
|
484.6
|
502
|
P/E ratio
|
-3.1
x
|
-2.75
x
|
-
|
Yield
|
-
|
-
|
-
|
Capitalization / Revenue
|
9,754
x
|
65.5
x
|
47.9
x
|
EV / Revenue
|
16,569
x
|
98.7
x
|
74.7
x
|
EV / EBITDA
|
-6.61
x
|
-3.92
x
|
-2.72
x
|
EV / FCF
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
Price to Book
|
-1.07
x
|
-1.45
x
|
-1.73
x
|
Nbr of stocks (in thousands)
|
47,897
|
-
|
-
|
Reference price
2 |
6.720
|
6.720
|
6.720
|
Announcement Date
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
0.12
|
0.033
|
4.912
|
6.717
|
EBITDA
1 |
-
|
-50.55
|
-82.76
|
-123.6
|
-184.6
|
EBIT
1 |
-
|
-50.84
|
-83.35
|
-112.8
|
-167.5
|
Operating Margin
|
-
|
-42,363.33%
|
-2,52,575.12%
|
-2,296.47%
|
-2,493.55%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-46.45
|
-94.27
|
-81.99
|
-127.8
|
-
|
Net margin
|
-
|
-78,559.17%
|
-2,48,442.42%
|
-2,602.48%
|
-
|
EPS
2 |
-14.90
|
-
|
-2.170
|
-2.440
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/08/23
|
01/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2024 Q1
|
---|
Net sales
1 |
0.033
|
EBITDA
|
-
|
EBIT
|
-
|
Operating Margin
|
-
|
Earnings before Tax (EBT)
|
-
|
Net income
1 |
-3.322
|
Net margin
|
-10,066.67%
|
EPS
|
-
|
Dividend per Share
|
-
|
Announcement Date
|
13/05/24
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
225
|
163
|
180
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-2.718
x
|
-1.317
x
|
-0.9758
x
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
-
|
-6.290
|
-4.630
|
-3.880
|
Cash Flow per Share
2 |
-
|
-
|
-1.850
|
-2.190
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
22/08/23
|
01/04/24
|
-
|
-
|
-
|
Last Close Price
6.72
USD Average target price
22
USD Spread / Average Target +227.38% Consensus |
1st Jan change
|
Capi.
|
---|
| 0.00% | 32Cr | | +8.92% | 11TCr | | +10.48% | 10TCr | | -6.45% | 2.38TCr | | -2.68% | 2.17TCr | | -10.46% | 1.81TCr | | -42.36% | 1.63TCr | | -14.45% | 1.61TCr | | +3.76% | 1.38TCr | | +28.94% | 1.18TCr |
Bio Therapeutic Drugs
|